2Faggioli P,De Paschale M.Tocci A,et al. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma. Haematologica 1997,82(1) :38.
3Lok ASF,Liang RHS,Chiu EKW,et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991,100(1):182.
4戴志澄.中国病毒性肝炎血清流行病学调查[M].北京:科学技术文献出版社,1997..
5Hausfater P, Cacoub P, Sterkers Y,et al. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France [J]. Am J Hematol, 2001,67:168-171.
6Aviles A, Valdez L, Halabe J, et al. No association between lymphoma and hepatitis C virus [J]. Med Oncol, 2003,20:165-168.
7Visona K, Baez F,Taylor L,et al. Impact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999 [J]. Clin Diagn Lab Immunol,2002,9:622-626.
8DeRosa G, Gobbo M L, DeRenzo A,et al. High prevalence Of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy [J]. Am J Hematol, 1997,55:77 -82.
9Harakati MS, Abualhair OA, Al-Knawy BA. Hepatitis C virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma[J]. Saudi Med J ,2003,2: 144-145.
10Izumi T, Sasaki R, Tsunoda S, et al. B cell malignancy and hepatitis C virus infection[J]. Leukemia,1997,3: 516-518.
